» Articles » PMID: 26550336

Can Red Cell Distribution Width Be a Marker of Disease Activity in Ulcerative Colitis?

Overview
Specialty General Medicine
Date 2015 Nov 10
PMID 26550336
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The current study aimed to investigate the association between disease activity and red cell distribution width (RDW) levels in ulcerative colitis and to determine whether RDW can be used as a marker of disease activity in non-anemic ulcerative colitis.

Methods: The RDW levels of 310 ulcerative colitis patients who underwent colonoscopy were analyzed retrospectively. The patients were divided into two groups (active disease and remission) according to the endoscopic activity index. In addition, the accuracy of RDW in determining disease activity in non-anemic patients was assessed. The efficacy of RDW in determining disease activity was compared to that of white blood cell count, platelet count, C-reactive protein, and erythrocyte sedimentation rate.

Results: Two hundred and six (66.5%) patients had active disease, and 104 (33.5%) were in remission. The mean RDW levels in patients with active ulcerative colitis and in those in remission were 16.8±2.9 and 15.5±1.4, respectively (P<0.001). Ninety-six (46.6%) patients in the active disease group and 89 (85.6%) in the remission group were non-anemic, and their respective RDW levels were 15.4±1.2 and 15.3±1.1 (P=0.267). The sensitivity and specificity of RDW in determining inflammation were 41% and 91%, respectively (AUC 0.65, P<0.001).

Conclusions: This study demonstrated that RDW can be used as a marker for disease activity in ulcerative colitis, but it did not have the same efficacy in the non-anemic group.

Citing Articles

Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review.

Katsaros M, Paschos P, Giouleme O Ann Gastroenterol. 2020; 33(4):348-354.

PMID: 32624654 PMC: 7315702. DOI: 10.20524/aog.2020.0486.


Time-Dependent Indirect Antioxidative Effects of Oat Beta-Glucans on Peripheral Blood Parameters in the Animal Model of Colon Inflammation.

Kopiasz L, Dziendzikowska K, Gajewska M, Wilczak J, Harasym J, Zyla E Antioxidants (Basel). 2020; 9(5).

PMID: 32365955 PMC: 7278816. DOI: 10.3390/antiox9050375.


Subclinical inflammation markers in hyperemesis gravidarum and ketonuria: A case-control study.

Cintesun E, Akar S, Gul A, Cintesun F, Sahin G, Ezveci H J Lab Physicians. 2019; 11(2):149-153.

PMID: 31160855 PMC: 6543934. DOI: 10.4103/JLP.JLP_151_18.


Prognostic significance of red blood cell distribution width in gastrointestinal disorders.

Goyal H, Lippi G, Gjymishka A, John B, Chhabra R, May E World J Gastroenterol. 2017; 23(27):4879-4891.

PMID: 28785142 PMC: 5526758. DOI: 10.3748/wjg.v23.i27.4879.

References
1.
Guagnozzi D, Severi C, Ialongo P, Viscido A, Patrizi F, Testino G . Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis. 2006; 12(2):150-1. DOI: 10.1097/01.MIB.0000199223.27595.e3. View

2.
Zhu A, Kaneshiro M, Kaunitz J . Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci. 2010; 55(3):548-59. PMC: 2822907. DOI: 10.1007/s10620-009-1108-6. View

3.
Oustamanolakis P, Koutroubakis I, Messaritakis I, Kefalogiannis G, Niniraki M, Kouroumalis E . Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis. 2011; 5(4):295-300. DOI: 10.1016/j.crohns.2011.02.002. View

4.
Hampole C, Mehrotra A, Thenappan T, Gomberg-Maitland M, Shah S . Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009; 104(6):868-72. DOI: 10.1016/j.amjcard.2009.05.016. View

5.
Vermeire S, Van Assche G, Rutgeerts P . Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut. 2006; 55(3):426-31. PMC: 1856093. DOI: 10.1136/gut.2005.069476. View